Abstract
Plasma lipidomic studies using high performance liquid chromatography and mass spectroscopy offer detailed insights into metabolic processes. Taking the example of the most abundant plasma lipid class (phosphatidylcholines) we used the rich phenotypic and lipidomic data from the ongoing San Antonio Family Heart Study of large extended Mexican–American families to assess the variability of association of the plasma phosphatidylcholine species with metabolic syndrome. Using robust statistical analytical methods, our study made two important observations. First, there was a wide variability in the association of phosphatidylcholine species with risk measures of metabolic syndrome. Phosphatidylcholine 40:7 was associated with a low risk while phosphatidylcholines 32:1 and 38:3 were associated with a high risk of metabolic syndrome. Second, all the odd chain phosphatidylcholines were associated with a reduced risk of metabolic syndrome implying that phosphatidylcholines derived from dairy products might be beneficial against metabolic syndrome. Our results demonstrate the value of lipid species-specific information provided by the upcoming array of lipidomic studies and open potential avenues for prevention and control of metabolic syndrome in high prevalence settings.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- DBP:
-
Diastolic blood pressure
- FG:
-
Fasting glucose
- FI:
-
Fasting insulin
- HDL:
-
High density lipoproteins
- IDF:
-
International diabetes federation
- LDL:
-
Low density lipoprotein
- MS:
-
Metabolic syndrome
- ROC:
-
Receiver operating characteristic
- SAFHS:
-
San Antonio family heart study
- SBP:
-
Systolic blood pressure
- TG:
-
Triglycerides
- TSC:
-
Total serum cholesterol
- WC:
-
Waist circumference
References
Meikle PJ, Christopher MJ (2011) Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol 22:210–215
Kontush A, Chapman MJ (2010) Lipidomics as a tool for the study of lipoprotein metabolism. Curr Atheroscler Rep 12:194–201
Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, Makkonen J, Taskinen MR, Oresic M, Yki-Jarvinen H (2009) Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52:684–690
Koerner TA, Cunningham MT, Zhang DS (1992) The role of membrane lipid in the platelet storage lesion. Blood Cells 18:481–497 (discussion 498–500)
MacCluer JW, Stern MP, Almasy L, Atwood LA, Blangero J, Comuzzie AG, Dyke B, Haffner SM, Henkel RD, Hixson JE et al (1999) Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev 57:S59–S65
Voruganti VS, Lopez-Alvarenga JC, Nath SD, Rainwater DL, Bauer R, Cole SA, Maccluer JW, Blangero J, Comuzzie AG (2008) Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans. J Mol Med (Berl) 86:303–311
IDF (2006) The IDF consensus worldwide definition of metabolic syndrome. IDF Communications, Brussels, Belgium
Murphy RC, James PF, McAnoy AM, Krank J, Duchoslav E, Barkley RM (2007) Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem 366:59–70
Smyth I, Hacking DF, Hilton AA, Mukhamedova N, Meikle PJ, Ellis S, Satterley K, Collinge JE, de Graaf CA, Bahlo M et al (2008) A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. PLoS Genet 4:e1000192
Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211
Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95:221–227
Cheverud JM (2001) A simple correction for multiple comparisons in interval mapping genome scans. Heredity (Edinb) 87:52–58
Melton PE, Rutherford S, Voruganti VS, Goring HH, Laston S, Haack K, Comuzzie AG, Dyer TD, Johnson MP, Kent JW Jr et al (2010) Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family Study. Hum Mol Genet 19:3662–3671
Diego VP, Goring HH, Cole SA, Almasy L, Dyer TD, Blangero J, Duggirala R, Laston S, Wenger C, Cantu T et al (2006) Fasting insulin and obesity-related phenotypes are linked to chromosome 2p: the Strong Heart Family Study. Diabetes 55:1874–1878
Almasy L, Dyer TD, Blangero J (1997) Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol 14:953–958
Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J (1997) Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 132:237–243
Ng DS, Saw NM (2012) The role of HDL and its modulators in the development of diabetes. Curr Opin Lipidol 23:167–168
Gaby AR (2009) Nutritional approaches to prevention and treatment of gallstones. Altern Med Rev 14:258–267
Nash DT (2004) Cardiovascular risk beyond LDL-C levels. Other lipids are performers in cholesterol story. Postgrad Med 116:11–15
Yanagita T, Nagao K (2008) Functional lipids and the prevention of the metabolic syndrome. Asia Pac J Clin Nutr 17(Suppl 1):189–191
Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T (2007) Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem 55:7170–7176
Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, Zhang CM, Wang Y, Liu P, Tu BB et al (2012) Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 10:153
Duncan D, Rubin JP, Golitz L, Badylak S, Kesel L, Freund J (2009) Refinement of technique in injection lipolysis based on scientific studies and clinical evaluation. Clin Plast Surg, 36:195–209 (v–vi; discussion 211–193)
Walker AK, Jacobs RL, Watts JL, Rottiers V, Jiang K, Finnegan DM, Shioda T, Hansen M, Yang F, Niebergall LJ et al (2011) A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell 147:840–852
Khaw KT, Friesen MD, Riboli E, Luben R, Wareham N (2012) Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 9:e1001255
Meissner T, Leichsenring M, Mayatepek E (2004) Odd-numbered long-chain fatty acids in erythrocyte phospholipids as long-term follow-up parameter in propionic acidemia. Clin Chem Lab Med 42:1005–1008
Wolk A, Furuheim M, Vessby B (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131:828–833
Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, Joost HG, Boeing H, Schulze MB (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 93:127–142
Kim OY, Lim HH, Lee MJ, Kim JY, Lee JH: (2011) Association of fatty acid composition in serum phospholipids with metabolic syndrome and arterial stiffness. Nutr Metab Cardiovasc Dis (epub ahead of print)
Pietilainen KH, Rog T, Seppanen-Laakso T, Virtue S, Gopalacharyulu P, Tang J, Rodriguez-Cuenca S, Maciejewski A, Naukkarinen J, Ruskeepaa AL et al (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9:e1000623
Acknowledgments
This work was supported in part by NIH grants R01 DK082610 and R01 DK079169. Data collection for the San Antonio Family Heart Study was supported by NIH grant P01 HL045522. We are grateful to the participants of the San Antonio Family Heart Study for their continued involvement. The development of the analytical methods and software used in this study was supported by NIH grant R37 MH059490. The AT&T Genomics Computing Center supercomputing facilities used for this work were supported in part by a gift from the AT&T Foundation and with support from the National Center for Research Resources Grant Number S10 RR029392. This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grants C06 RR013556 and C06 RR017515 from the National Center for Research Resources of the National Institutes of Health.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kulkarni, H., Meikle, P.J., Mamtani, M. et al. Variability in Associations of Phosphatidylcholine Molecular Species with Metabolic Syndrome in Mexican–American Families. Lipids 48, 497–503 (2013). https://doi.org/10.1007/s11745-013-3781-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-013-3781-7